Literature DB >> 15950738

Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling.

Wei Zhang1, Jiannan Feng, Yan Li, Ning Guo, Beifen Shen.   

Abstract

The murine monoclonal antibody Z12 is of therapeutic interest for its neutralizing biological activity against human tumor necrosis factor-alpha (hTNF-alpha). We attempted to humanize Z12 with variable domain resurfacing guided by computer modeling. First, the genes of heavy and light chain variable region (VH, VL) of Z12 were cloned and the whole three-dimensional structure of Fv fragment was constructed by using homology-based modeling and molecular docking methods. Then the complex model of Fv interacting with hTNF-alpha whose crystal structure derived from PDB database was gained with computer-guided docking program. Based on this model, a humanized version was designed. The humanized Fab antibody was constructed, expressed and purified in the pComb3H vector system and it showed unaltered binding affinity to the antigen as determined by ELISA and atomic force microscopy (AFM). The method described here can be used to humanize other anti-hTNF-alpha antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950738     DOI: 10.1016/j.molimm.2005.01.015

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library.

Authors:  Longlong Luo; Shi Wang; Xiaoling Lang; Tingting Zhou; Jing Geng; Xinying Li; Chunxia Qiao; Jiannan Feng; Beifen Shen; Ming Lv; Yan Li
Journal:  Cell Mol Immunol       Date:  2016-08-08       Impact factor: 11.530

2.  Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.

Authors:  Wei-Chun Chiu; Ya-Ping Lai; Min-Yuan Chou
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

3.  Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.

Authors:  Nives Skrlj; Tanja Vranac; Mara Popović; Vladka Curin Šerbec; Marko Dolinar
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

4.  Design and Construction of a Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor Alpha.

Authors:  Davoud Farajzadeh; Sadigheh Karimi-Gharigh; Parisa Jalali-Kondori; Siavoush Dastmalchi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.